✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Non-MedicalOff-Topic Why This MattersThis appears to be a general news story about detention conditions...
Medically Recommended Cannabis Use for US Adolescents.
As more states legalize medical cannabis, there is growing interest in its use in adolescents. This nationally-representative study assesses the prevalence o…
Cannabidiol in Developmental Epilepsy: Organoid-Guided Precision Medicine Across Critical Neurodevelopmental Windows.
Epilepsy is a progressive network disorder in which recurrent seizures drive maladaptive neurodevelopmental remodeling, cognitive decline, and pharmacoresist…
Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2 deletion syndrome (ZYN2-CL-031).
CED Clinical Relevance #64Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch | CED Clinic CbdPediatricNeurodevelopmentalTransdermalOpen-Label JournalJournal of neurodevelopmental disordersStudy TypeOpen-Label TrialPopulationHuman participants Why This Matters22q11.2 deletion syndrome affects 1 in...
Colorado: Data Finds No Evidence of Underage Cannabis Sales at Licensed Retailers
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Adolescent HealthCannabis PolicyHarm ReductionRegulatory CompliancePediatrics Why This MattersThis regulatory compliance data provides important context...
Drugs detected in suspected pediatric exposures: a 5-year review.
Given new prescription medications, designer drugs and changes in drug laws, updated data on the most common drugs and compounds in patients presenting with …
Parent and caregiver perceptions of cannabidiol products may put children at risk for unintentional exposure.
Rapid growth in the cannabidiol (CBD) market has been temporally associated with increasing emergency department (ED) visits related to cannabis exposure in …
Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support.
Oral cannabidiol (CBD) treatment has been suggested to alleviate severe symptoms of autism spectrum disorder (ASD). While many CBD preparations have been stu…
Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children: A Randomized Controlled Crossover Trial.
Cannabidiol (CBD), a non-intoxicating compound derived from the cannabis plant, has garnered increasing attention as a potential pharmacological therapeutic …
Medical Cannabis and Epilepsy: The Evidence.
Epilepsy is a serious neurological condition that can affect individuals of all ages. Treatment is far from perfect, and roughly 30% of patients can experien…